CompoundedNAD+

No. Compounded NAD+ injection has not undergone FDA premarket review, and the FDA has not reviewed a compounded NAD+ formulation for safety, effectiveness or quality before marketing. That disclosure is required and it is the plain fact: a compounded preparation is made for one patient rather than manufactured and reviewed in advance.

Formulation, concentration, inactive ingredients, dosing and administration instructions may differ depending on the dispensing pharmacy and the individual prescription. Your medication arrives with instructions specific to what you were prescribed, and your provider can answer anything the label does not.

Allergies, kidney or liver disease, chronic or significant medical conditions, pregnancy or breastfeeding, and every prescription medication, supplement and injectable therapy you use. Injectables interact with more than people expect, and the visit is where that gets caught.

Possible reactions may include injection-site pain, redness, swelling or irritation, nausea, lightheadedness, flushing or warmth, headache, and hypersensitivity or allergic reactions. Seek immediate medical attention for symptoms of a serious allergic reaction. Tell your provider about any side effect you experience.

An independent state-licensed pharmacy compounds and dispenses it; Koves is a technology platform and does not compound, dispense or control medications. It ships free, in plain packaging, with nothing on the outside naming the medication.